Agenus posts results for zalifrelimab plus balstilimab trial in advanced cervical cancerAug 11Trial updateAgenus Inc.balstilimab
Agenus advances Phase 3 ROBBIN trial in colon cancer, backed by July financingAug 6Quarterly updateAgenus Inc.
Dana-Farber registers Phase 2 trial of Agenus drugs in early rectal cancerJul 30Trial updateAgenus Inc.balstilimab
Agenus secures up to $340 million to fund Phase 3 ROBBIN trial in MSS colon cancerJul 13Clinical readoutAgenus Inc.
Sign inSign in